AP1B1
AP-1 complex subunit beta-1
Also known as: ADTB1, AP105A, AP1B1_HUMAN, BAM22, CLAPB2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q10567
- Gene
- AP1B1
- Ensembl
- ENSG00000100280
- Chromosome
- 22
- Canonical length
- 949 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters
- Subcellular location
- Golgi apparatus,Vesicles,Cytosol
OverviewNCBI Gene
Adaptor protein complex 1 is found at the cytoplasmic face of coated vesicles located at the Golgi complex, where it mediates both the recruitment of clathrin to the membrane and the recognition of sorting signals within the cytosolic tails of transmembrane receptors. This complex is a heterotetramer composed of two large, one medium, and one small adaptin subunit. The protein encoded by this gene serves as one of the large subunits of this complex and is a member of the adaptin protein family. This gene is a candidate meningioma gene. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
Canonical amino-acid sequenceUniProt
949 residues, UniProt reviewed canonical sequence.
>Q10567|AP1B1
1 MTDSKYFTTT KKGEIFELKA ELNSDKKEKK KEAVKKVIAS MTVGKDVSAL FPDVVNCMQT
61 DNLELKKLVY LYLMNYAKSQ PDMAIMAVNT FVKDCEDPNP LIRALAVRTM GCIRVDKITE
121 YLCEPLRKCL KDEDPYVRKT AAVCVAKLHD INAQLVEDQG FLDTLKDLIS DSNPMVVANA
181 VAALSEIAES HPSSNLLDLN PQSINKLLTA LNECTEWGQI FILDCLANYM PKDDREAQSI
241 CERVTPRLSH ANSAVVLSAV KVLMKFMEML SKDLDYYGTL LKKLAPPLVT LLSAEPELQY
301 VALRNINLIV QKRPEILKHE MKVFFVKYND PIYVKLEKLD IMIRLASQAN IAQVLAELKE
361 YATEVDVDFV RKAVRAIGRC AIKVEQSAER CVSTLLDLIQ TKVNYVVQEA IVVIKDIFRK
421 YPNKYESVIA TLCENLDSLD EPEARAAMIW IVGEYAERID NADELLESFL EGFHDESTQV
481 QLQLLTAIVK LFLKKPTETQ ELVQQVLSLA TQDSDNPDLR DRGYIYWRLL STDPVAAKEV
541 VLAEKPLISE ETDLIEPTLL DELICYIGTL ASVYHKPPSA FVEGGRGVVH KSLPPRTASS
601 ESAESPETAP TGAPPGEQPD VIPAQGDLLG DLLNLDLGPP VSGPPLATSS VQMGAVDLLG
661 GGLDSLMGDE PEGIGGTNFV APPTAAVPAN LGAPIGSGLS DLFDLTSGVG TLSGSYVAPK
721 AVWLPAMKAK GLEISGTFTR QVGSISMDLQ LTNKALQVMT DFAIQFNRNS FGLAPAAPLQ
781 VHAPLSPNQT VEISLPLSTV GSVMKMEPLN NLQVAVKNNI DVFYFSTLYP LHILFVEDGK
841 MDRQMFLATW KDIPNENEAQ FQIRDCPLNA EAASSKLQSS NIFTVAKRNV EGQDMLYQSL
901 KLTNGIWVLA ELRIQPGNPS CTDLELSLKC RAPEVSQHVY QAYETILKNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AP1B1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 63 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 63 nTPM
- esophagus: 61 nTPM
- spleen: 54 nTPM
- lymph node: 54 nTPM
- tonsil: 51 nTPM
- cerebral cortex: 48 nTPM
Single-cell type
- hofbauer cells: 305 nCPM
- microglia: 265 nCPM
- rod photoreceptor cells: 189 nCPM
- kupffer cells: 184 nCPM
- macrophages: 164 nCPM
- cone photoreceptor cells: 143 nCPM
Immune cell
- non-classical monocyte: 32 nTPM
- classical monocyte: 29 nTPM
- intermediate monocyte: 29 nTPM
- myeloid DC: 29 nTPM
- total PBMC: 24 nTPM
- naive B-cell: 18 nTPM
Brain region
- thalamus: 107 nTPM
- white matter: 100 nTPM
- midbrain: 92 nTPM
- pons: 90 nTPM
- medulla oblongata: 89 nTPM
- spinal cord: 85 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about AP1B1.
Disease | AllUniProt
Conditions AP1B1 is implicated in, by any mechanism.
- Keratitis-ichthyosis-deafness syndrome, autosomal recessive (KIDAR) MIM:242150
Disease | GeneticClinVar
12 pathogenic / likely-pathogenic of 185 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal recessive keratitis-ichthyosis-deafness syndrome
- AP1B1-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.26
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.12
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- basolateral protein secretion
- determination of left/right symmetry
- heart development
- intracellular protein transport
- kidney development
- melanosome assembly
- platelet dense granule organization
- vesicle-mediated transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Armadillo
- Clathrin/coatomer adaptor, adaptin-like, N-terminal
- Clathrin adaptor, alpha/beta/gamma-adaptin, appendage, Ig-like subdomain
- Coatomer/calthrin adaptor appendage, C-terminal subdomain
- Armadillo-like helical
- TBP domain superfamily
- Clathrin adaptor, beta-adaptin, appendage, Ig-like subdomain
- Clathrin adaptor, appendage, Ig-like subdomain superfamily
- Beta-adaptin appendage, C-terminal subdomain
- Armadillo-type fold
- AP-1/2/4 complex subunit beta
- AP complex subunit beta
- Adaptin N terminal region
- Adaptin C-terminal domain
- Beta2-adaptin appendage, C-terminal sub-domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AP1B1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AP1B1 as an antibody target. Whether an autoantibody or antibody against AP1B1 could matter depends on whether native AP1B1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AP1B1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AP1B1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...